J Clin Med Res
Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc
Journal website http://www.jocmr.org

Correction

Volume 11, Number 6, June 2019, page 464


Correction to: The Gonadotropin-Releasing Hormone Analogue Therapy May Not Impact Final Height in Precocious Puberty of Girls With Onset of Puberty Aged 6 - 8 Years

Ozlem Korkmaza, c, Gulsenem Sarib, Ilkin Mecidova, Samim Ozena, Damla Goksena, Sukran Darcana

aDepartment of Pediatric Endocrinology, School of Medicine, Ege University, Izmir, Turkey
bDepartment of Pediatrics, School of Medicine, Ege University, Izmir, Turkey
cCorresponding Author: Ozlem Korkmaz, Department of Pediatric Endocrinology, School of Medicine, Ege University, Bornova 35100, Izmir, Turkey. Email :

Manuscript submitted April 22, 2019, accepted April 25, 2019
Short title: Correction
doi: https://doi.org/10.14740/jocmr3710-c

This is to correct the published article, Journal of Clinical Medicine Research, 2019;11(2):133-136. DOI: 10.14740/jocmr3710.

The authors would like to make the corrections as follows.

In abstract section, paragraph 3, change “Fourteen cases received monthly 3.75 mg depot triptorelin acetate and 11 received three-monthly 11.25 mg depot” to “Fourteen cases received monthly 3.75 mg depot triptorelin acetate and 11 received three-monthly 11.25 mg depot leuprolide acetate.”

In materials and methods section, paragraph 2, change “Fourteen of the treated cases received monthly 3.75 mg depot triptorelin acetate 75 - 100 µg/kg, while 11 received three monthly 11.25 mg depot triptorelin acetate” to ‘Fourteen of the treated cases received monthly 3.75 mg depot triptorelin acetate 75 - 100 µg/kg, while 11 received three monthly 11.25 mg depot leuprolide acetate.”

In results section, paragraph 1, change “Patients of the treatment group received two different treatment regimens including 14 cases (56%) who received monthly 3.75 mg triptorelin acetate 75 - 100 µg/kg and 11 cases (44%) who received three-monthly 11.25 mg depot triptorelin acetate” to “Patients of the treatment group received two different treatment regimens including 14 cases (56%) who received monthly 3.75 mg triptorelin acetate 75 - 100 µg/kg and 11 cases (44%) who received three-monthly 11.25 mg depot leuprolide acetate.”

In results section, paragraph 6, change “No difference was determined in terms of initial height SDS, bone age, length of treatment, final height SDS or BMI SDS values between groups receiving monthly 3.75 mg triptorelin acetate or three-monthly 11.25 mg depot triptorelin acetate treatment (P > 0.05)” to “No difference was determined in terms of initial height SDS, bone age, length of treatment, final height SDS or BMI SDS values between groups receiving monthly 3.75 mg triptorelin acetate or three-monthly 11.25 mg depot leuprolide acetate treatment (P > 0.05).”



This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


Journal of Clinical Medicine Research is published by Elmer Press Inc.

 

Browse  Journals  

 

Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

 

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

 

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

 

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

 

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 
       
 

Journal of Clinical Medicine Research, monthly, ISSN 1918-3003 (print), 1918-3011 (online), published by Elmer Press Inc.                     
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.jocmr.org   editorial contact: editor@jocmr.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.